Publication | Open Access
Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma
55
Citations
22
References
2023
Year
ClinicalTrials.gov Identifier: NCT03077828.
| Year | Citations | |
|---|---|---|
Page 1
Page 1